Download PDF
Exp Clin Endocrinol Diabetes 2007; 115(1): 38-41
DOI: 10.1055/s-2007-948213
Article

© J. A. Barth Verlag in Georg Thieme Verlag KG · Stuttgart · New York

Association of Low-Grade Inflammation with Nephropathy in Type 2 Diabetic Patients: Role of Elevated CRP-Levels and 2 Different Gene-Polymorphisms of Proinflammatory Cytokines

H. Abrahamian 2 [*] , G. Endler 1 [*] , M. Exner 1 , H. Mauler 2 , M. Raith 1 , L. Endler 1 , H. Rumpold 1 , M. Gerdov 1 , C. Mannhalter 1 , R. Prager 2 , K. Irsigler 3 , O. F. Wagner 1
  • 1Department of Medical and Chemical Laboratory Diagnostics, University of Vienna, Medical School
  • 23rd medical department, Krankenhaus Lainz, Austria
  • 3Ludwig Boltzmann Research Institute for Metabolic Diseases, Vienna, Austria
Further Information

Publication History

Received 12.7.2005 First decision 29.5.2006

Accepted 27.6.2006

Publication Date:
07 February 2007 (online)

Also available at
    Permissions and Reprints

Abstract

Background:Chronic inflammatory processes are thought to play a key role in the development of micro- and macrovascular complications in type 2 diabetes mellitus. An association between low -grade inflammation and type 2 diabetes has been described in some studies. We assayed the association of two frequent polymorphisms in proinflammatory cytokines: the interleukin 6 G(-174)C promoter polymorphism [IL-6G(-174)C], the exon 2 interleukin receptor antagonist insertion deletion polymorphism [IL1RA]) and serum CRP levels with the prevalence of diabetic nephropathy in patients suffering from type 2 diabetes mellitus.

Subjects and methods:A total of 141 patients with type 2 diabetes mellitus, with and without diabetic nephropathy was genotyped for the above mentioned polymorphisms: 66 with normoalbuminuria, 31 with microalbuminuria and 44 with macroalbuminuria. CRP levels were analysed by a high sensitivity - immunnephelometric assay.

Results:While a significant association be-tween macroalbuminuria and CRP could be observed (p<0,015), no associations were found between IL-6G(-174)C or IL1RA genotype and any stage of nephropathy. CRP-levels were similiar in the 3 different IL-6G(-174)C genotypes as well as in the 2 IL1RA genotypes.

Conclusions:In type 2 diabetic subjects elevated CRP levels are associated with an increased prevalence of albuminuria. The two investigated proinflammatory polymorphisms do not seem to contribute to initiation of nephropathy in type 2 diabetic patients but we cannot exclude effects of these polymorphisms on course of nephropathy.

Key words

low grade inflammation - diabetes type 2 - diabetic nephropathy - proinflammatory polymorphisms

References

  • 1 Blakemore AI, Cox A, Gonzalez AM, Maskil JK, Hughes ME, Wilson RM. Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus.  Hum Genet. 1996;  97 369-374
    PubMedGoogle Scholar
  • 2 Du Clos TW. Function of C-reactive protein.  Ann Med. 2000;  32 274-278
    PubMedGoogle Scholar
  • 3 Festa A, D’Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.  Kidney Int. 2000;  58 1703-1710
    CrossrefPubMedGoogle Scholar
  • 4 Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.  J Clin Invest. 1998;  102 1369-1376
    CrossrefPubMedGoogle Scholar
  • 5 Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM. et al . C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk.  Arterioscler Thromb Vasc Biol. 2002;  22 593-598
    PubMedGoogle Scholar
  • 6 Kamiuchi K, Hasegawa G, Obayashi H, Kitamura A, Ishii M, Yano M. Leukocyte- endothelial cell adhesion molecule 1 (LECAM-1) polymorphism is associated with diabetic nephropathy in type 2 diabetes mellitus.  J Diabetes Complications. 2002;  16 333-337
    CrossrefPubMedGoogle Scholar
  • 7 Kubaszek A, Pihlajamaki J, Komarovski V, Lindi V, Lindstrom J, Eriksson J. Finnish Diabetes Prevention Study . Promoter polymorphisms of the TNF-alpha (G-308A) and IL (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study.  Diabetes. 2003;  52 1872-1876
    CrossrefPubMedGoogle Scholar
  • 8 Mangge H, Schauenstein K, Stroedter L, Griesl A, Maerz W, Borkenstein M. Low grade inflammation in juvenile obesity and type 1 diabetes associated with early signs of atherosclerosis.  Exp Clin Endocrinol Diabetes. 2004;  112 378-382
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Marculescu R, Endler G, Schillinger M, Iordanova N, Exner M, Hayden E. Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes.  Diabetes. 2002;  51 3582-3585
    CrossrefPubMedGoogle Scholar
  • 10 Navarro JF, Mora C, Maca M, Garca J. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus.  Am J Kidney Dis. 2003;  42 53-61
    CrossrefPubMedGoogle Scholar
  • 11 Ortega O, Rodriguez I, Gallar P, Carreno A, Ortiz M, Espejo B, Jimenez J, Gutierrez M, Oliet A, Vigil A. Significance of high C-reactive protein levels in pre-dialysis patients.  Nephrol Dial Transplant. 2002;  17 1105-1109
    PubMedGoogle Scholar
  • 12 Otto C, Engelschalk C, Fraunberger P, Laubach E, Schwandt P. Lack of an association of urinary albumin excretion with interleukin-6 or C-reactive protein in patients with type 2 diabetes.  Acta Diabetol. 2001;  38 153-155
    CrossrefPubMedGoogle Scholar
  • 13 Remuzzi G, Schieppati A, Ruggenenti P. Clinical practice. Nephropathy in patients with type 2 diabetes.  N Engl J Med. 2002;  346 1145-1151
    CrossrefPubMedGoogle Scholar
  • 14 Saraheimo M, Teppo AM, Forsblom C, Fagerudd J, Groop PH. the FinnDiane Study Group . Diabetic nephropathy is associated with low-grade inflammation in type 1 diabetic patients.  Diabetologia. 2003;  46 1402-1407
    CrossrefPubMedGoogle Scholar
  • 15 Schwedler S, Guderian F, Dämmrich J, Lawrence AP, Wanner CH. Tubular staining of modified C-reactive protein in diabetic chronic kidney disease.  Nephrol Dial Transplant. 2003;  18 2300-2307
    PubMedGoogle Scholar
  • 16 Singleton JR, Smith AG, Russell JW, Feldmann EL. Microvascular complications of impaired glucose tolerance.  Diabetes. 2003;  52 2867-2873
    CrossrefPubMedGoogle Scholar
  • 17 Solini A, Dalla Vestra M, Saller A, Nosadini R, Crepaldi G, Fioretto P. The angiotensin- converting enzyme DD genotype is associated with glomerulopathy lesions in type 2 diabetes.  Diabetes. 2002;  51 251-255
    PubMedGoogle Scholar
  • 18 Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes.  Diabetes. 2002;  51 1157-1165
    CrossrefPubMedGoogle Scholar
  • 19 Streja D, Cressey P, Rabkin SW. Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus.  J Diabetes Complications. 2003;  17 120-127
    CrossrefPubMedGoogle Scholar
  • 20 Taniwaki H, Ishimura E, Matsumoto N, Emoto M, Inaba M, Nishizawa Y. Relations between ACE gene and ecNOS gene polymorphisms and resistive index in type 2 diabetic patients with nephropathy.  Diabetes Care. 2001;  24 1653-1660
    PubMedGoogle Scholar
  • 21 Yue DK, McLennan SV, Turtle JR. Pathogenesis of diabetic microangiopathy: the roles of endothelial cell and basement membrane abnormalities.  Diabet Med. 1992;  9 218-223
    PubMedGoogle Scholar

1 H.A. and G.E. contributed equally to the present paper

Correspondence

H. Abrahamian

City Hospital Vienna Lainz

3rd Medical Department

Wolkersbergenstrasse 1

1130 Vienna

Austria

Phone: +43(1)80110

Fax: +43(1)801102346

      >